379 results on '"Brian Green"'
Search Results
2. A novel maturity index for assessing medical device startups
- Author
-
Frances J. Richmond, Grzegorz Zapotoczny, Brian Green, Sowmya Lokappa, Katy Rudnick, Juan Espinoza, and the ICRS-CTIP Collaborative for Regulatory Research
- Subjects
Pediatrics ,medical devices ,regulatory science ,business maturity ,startups ,clinical readiness ,small- and medium-sized enterprises ,Medicine - Abstract
Abstract Background: Startup companies in the healthcare sector often fail because they lack sufficient entrepreneurial, regulatory, and business development expertise. Maturity models provide useful frameworks to assess the state of business elements more systematically than heuristic assessments. However, previous models were developed primarily to characterize the business state of larger nonmedical companies. A maturity index designed specifically for startup companies in the medical product sector could help to identify areas in which targeted interventions could assist business development. Methods: A novel MedTech Startup Maturity Index (SMI) was developed by a collaborative team of academic and industry experts and refined through feedback from external stakeholders. Pediatric medical device startups associated with the West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) were scored and ranked according to the SMI following semi-structured interviews. The CTIP executive team independently ranked the maturity of each company based on their extensive experiences with the same companies. Results: SMI scores for 16 companies ranged from 1.2 to 3.8 out of 4. These scores were well aligned with heuristic CTIP rankings for 14 out of 16 companies, reflected by strong correlations between the two datasets (Spearman’s rho = 0.721, P = 0.002, and Kendall’s tau-b = 0.526, P = 0.006). Conclusions: The SMI yields maturity scores that correlate well with expert rankings but can be assessed without prior company knowledge and can identify specific areas of concern more systematically. Further research is required to generalize and validate the SMI as a pre-/post-evaluation tool.
- Published
- 2022
- Full Text
- View/download PDF
3. Seroconversion and fever are dose-dependent in a nonhuman primate model of inhalational COVID-19.
- Author
-
Paul A Dabisch, Jennifer Biryukov, Katie Beck, Jeremy A Boydston, Jaleal S Sanjak, Artemas Herzog, Brian Green, Gregory Williams, John Yeager, Jordan K Bohannon, Brian Holland, David Miller, Amy L Reese, Denise Freeburger, Susan Miller, Tammy Jenkins, Sherry Rippeon, James Miller, David Clarke, Emmanuel Manan, Ashley Patty, Kim Rhodes, Tina Sweeney, Michael Winpigler, Owen Price, Jason Rodriguez, Louis A Altamura, Heather Zimmerman, Alec S Hail, Victoria Wahl, and Michael Hevey
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Biology (General) ,QH301-705.5 - Abstract
While evidence exists supporting the potential for aerosol transmission of SARS-CoV-2, the infectious dose by inhalation remains unknown. In the present study, the probability of infection following inhalation of SARS-CoV-2 was dose-dependent in a nonhuman primate model of inhalational COVID-19. The median infectious dose, assessed by seroconversion, was 52 TCID50 (95% CI: 23-363 TCID50), and was significantly lower than the median dose for fever (256 TCID50, 95% CI: 102-603 TCID50), resulting in a group of animals that developed an immune response post-exposure but did not develop fever or other clinical signs of infection. In a subset of these animals, virus was detected in nasopharyngeal and/or oropharyngeal swabs, suggesting that infected animals without signs of disease are able to shed virus and may be infectious, which is consistent with reports of asymptomatic spread in human cases of COVID-19. These results suggest that differences in exposure dose may be a factor influencing disease presentation in humans, and reinforce the importance of public health measures that limit exposure dose, such as social distancing, masking, and increased ventilation. The dose-response data provided by this study are important to inform disease transmission and hazard modeling, and, ultimately, mitigation strategies. Additionally, these data will be useful to inform dose selection in future studies examining the efficacy of therapeutics and vaccines against inhalational COVID-19, and as a baseline in healthy, young adult animals for assessment of the importance of other factors, such as age, comorbidities, and viral variant, on the infectious dose and disease presentation.
- Published
- 2021
- Full Text
- View/download PDF
4. Comparative Pathogenesis of Asian and African-Lineage Zika Virus in Indian Rhesus Macaque’s and Development of a Non-Human Primate Model Suitable for the Evaluation of New Drugs and Vaccines
- Author
-
Jonathan O. Rayner, Raj Kalkeri, Scott Goebel, Zhaohui Cai, Brian Green, Shuling Lin, Beth Snyder, Kimberly Hagelin, Kevin B. Walters, and Fusataka Koide
- Subjects
Zika virus ,ZIKV ,rhesus macaques ,Non-human primates ,NHP ,infection ,natural history ,Asian-lineage ,African-lineage ,Microbiology ,QR1-502 - Abstract
The establishment of a well characterized non-human primate model of Zika virus (ZIKV) infection is critical for the development of medical interventions. In this study, challenging Indian rhesus macaques (IRMs) with ZIKV strains of the Asian lineage resulted in dose-dependent peak viral loads between days 2 and 5 post infection and a robust immune response which protected the animals from homologous and heterologous re-challenge. In contrast, viremia in IRMs challenged with an African lineage strain was below the assay’s lower limit of quantitation, and the immune response was insufficient to protect from re-challenge. These results corroborate previous observations but are contrary to reports using other African strains, obviating the need for additional studies to elucidate the variables contributing to the disparities. Nonetheless, the utility of an Asian lineage ZIKV IRM model for countermeasure development was verified by vaccinating animals with a formalin inactivated reference vaccine and demonstrating sterilizing immunity against a subsequent subcutaneous challenge.
- Published
- 2018
- Full Text
- View/download PDF
5. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.
- Author
-
Tobias Schwarzmüller, Biao Ma, Ekkehard Hiller, Fabian Istel, Michael Tscherner, Sascha Brunke, Lauren Ames, Arnaud Firon, Brian Green, Vitor Cabral, Marina Marcet-Houben, Ilse D Jacobsen, Jessica Quintin, Katja Seider, Ingrid Frohner, Walter Glaser, Helmut Jungwirth, Sophie Bachellier-Bassi, Murielle Chauvel, Ute Zeidler, Dominique Ferrandon, Toni Gabaldón, Bernhard Hube, Christophe d'Enfert, Steffen Rupp, Brendan Cormack, Ken Haynes, and Karl Kuchler
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Biology (General) ,QH301-705.5 - Abstract
The opportunistic fungal pathogen Candida glabrata is a frequent cause of candidiasis, causing infections ranging from superficial to life-threatening disseminated disease. The inherent tolerance of C. glabrata to azole drugs makes this pathogen a serious clinical threat. To identify novel genes implicated in antifungal drug tolerance, we have constructed a large-scale C. glabrata deletion library consisting of 619 unique, individually bar-coded mutant strains, each lacking one specific gene, all together representing almost 12% of the genome. Functional analysis of this library in a series of phenotypic and fitness assays identified numerous genes required for growth of C. glabrata under normal or specific stress conditions, as well as a number of novel genes involved in tolerance to clinically important antifungal drugs such as azoles and echinocandins. We identified 38 deletion strains displaying strongly increased susceptibility to caspofungin, 28 of which encoding proteins that have not previously been linked to echinocandin tolerance. Our results demonstrate the potential of the C. glabrata mutant collection as a valuable resource in functional genomics studies of this important fungal pathogen of humans, and to facilitate the identification of putative novel antifungal drug target and virulence genes.
- Published
- 2014
- Full Text
- View/download PDF
6. Dynamic Screen Space Textures for Coherent Stylization.
- Author
-
Brent Burley, Brian Green, and Daniel Teece
- Published
- 2024
- Full Text
- View/download PDF
7. Vectorized production path tracing.
- Author
-
Mark Lee, Brian Green, Feng Xie, and Eric Tabellion
- Published
- 2017
- Full Text
- View/download PDF
8. Path tracing in production - part 1: production renderers.
- Author
-
Luca Fascione, Johannes Hanika, Marcos Fajardo, Per H. Christensen, Brent Burley, and Brian Green
- Published
- 2017
- Full Text
- View/download PDF
9. Use of Risk Information to Support NRC Human Factors License Amendment Reviews, Inspections, and Research.
- Author
-
Brian Green and Jing Xing
- Published
- 2017
- Full Text
- View/download PDF
10. Predictable and Targeted Softening of the Shadow Terminator.
- Author
-
Priyamvad Deshmukh and Brian Green
- Published
- 2020
- Full Text
- View/download PDF
11. Gravity Wave Phase Speeds, Wavelengths, and Momentum Fluxes Observed Above the Southern Ocean
- Author
-
Brian Green and Aditi Sheshadri
- Abstract
From March to December 2014, Loon LLC flew 107 super-pressure balloons in the lower stratosphere over the Southern Ocean. Their GPS sampling frequency of 1Hz allowed them to sample motion associated with atmospheric internal gravity waves generated by the Andes mountains, small islands, and non-orographic sources such as fronts. Analyzing the balloons’ data time series using wavelets, we present distributions of the gravity waves’ momentum fluxes, phase speeds, and wavelengths, both in the time-mean and as they vary from month to month. Many climate models parameterize gravity waves using a phase speed-momentum flux relationship, so we focus on the relationship between those quantities.
- Published
- 2023
12. Suggested updates for the inclusion of guidance on ultra-high performance concrete to USACE Engineering Manual 1110-2-2000, Standard Practice for Concrete for Civil Works Structures
- Author
-
Dylan Scott, Stephanie Wood, Brian Green, and Bradford Songer
- Abstract
Ultra-high performance concrete (UHPC) is a relatively modern class of concrete with properties that include very high compressive strengths, increased tensile strengths, very low permeability, and superior durability compared to conventional, normal-strength concrete. As research of this material continues to progress, its applications under both military and civil works categories expand. However, mixture and structural design guidance using UHPC is limited, particularly in the United States. This special report provides an overview of UHPC as initial guidance for the US Army Corps of Engineers (USACE) so that the material may be more easily utilized in civil works infrastructure. The information contained in this report is based on years of experience researching and developing UHPC at the US Army Engineer Research and Development Center (ERDC) and is intended to be a basis for the incorporation of this material class into USACE Engineer Manual (EM) 1110-2-2000, Standard Practice for Concrete for Civil Works Structures, when it is next updated.
- Published
- 2023
13. Recreating observed convection-generated gravity waves from weather radar observations via a neural network and a dynamical atmospheric model
- Author
-
Christopher G Kruse, M. Joan Alexander, Martina Bramberger, Ashesh Chattopadhyay, Pedram Hassanzadeh, Brian Green, Alison W. Grimsdell, and Lars Hoffmann
- Abstract
Convection-generated gravity waves (CGWs) transport momentum and energy, and this momentum is a dominant driver of global features of Earth’s atmosphere’s general circulation (e.g. the quasi-biennial oscillation, the pole-to-pole mesospheric circulation). As CGWs are not generally resolved by global weather and climate models, their effects on the circulation need to be parameterized. However, quality observations of GWs are spatiotemporally sparse, limiting understanding and preventing constraints on parameterizations. Convection-permitting or -resolving simulations do generate CGWs, but validation is not possible as these simulations cannot reproduce the forcing convection at correct times, locations, and intensities.Here, realistic convective diabatic heating, learned from full-physics convection-permitting Weather Research and Forecasting (WRF) simulations, is predicted from weather radar observations using neural networks and a previously developed look-up table. These heating rates are then used to force an idealized GW-resolving dynamical model. Simulated CGWs forced in this way did closely resemble those observed by the Atmospheric InfraRed Sounder in the upper stratosphere. CGW drag in these validated simulations extends 100s of kilometers away from the convective sources, highlighting errors in current gravity wave drag parameterizations due to the use of the ubiquitous single-column approximation. Such validatable simulations have significant potential to be used to further basic understanding of CGWs, improve their parameterizations physically, and provide more restrictive constraints on tuning \textit{with confidence}.
- Published
- 2023
14. Comparison of Dose-Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19
- Author
-
Paul A. Dabisch, Jaleal S. Sanjak, Jeremy A. Boydston, John Yeager, Artemas Herzog, Jennifer Biryukov, Katie Beck, Danh Do, Brittany G. Seman, Brian Green, Jordan K. Bohannon, Brian Holland, David Miller, Taylor Ammons, Denise Freeburger, Susan Miller, Tammy Jenkins, Sherry Rippeon, James Miller, David Clarke, Emmanuel Manan, Ashley Patty, Kim Rhodes, Tina Sweeney, Michael Winpigler, Louis A. Altamura, Heather Zimmerman, Alec S. Hail, Victoria Wahl, and Michael Hevey
- Subjects
Pulmonary and Respiratory Medicine ,Pharmaceutical Science ,Pharmacology (medical) - Published
- 2022
15. Global Solutions vs. Local Solutions for the AI Safety Problem.
- Author
-
Alexey Turchin, David Denkenberger, and Brian Green
- Published
- 2019
- Full Text
- View/download PDF
16. Child With Recurrent Pruritic Skin Lesions
- Author
-
Brian, Green, Meloria, Hoskins, and Laurie, Krnjaic
- Subjects
Pruritus ,Humans ,Child ,Skin Diseases ,Skin - Published
- 2022
17. Comparison of the performance of aerosol sampling devices for measuring infectious SARS-CoV-2 aerosols
- Author
-
Paul A. Dabisch, Kyle Bohannon, Denise Freeburger, Gregory D. Williams, Melissa Krause, Brian Holland, Brian Green, and Shanna Ratnesar-Shumate
- Subjects
010504 meteorology & atmospheric sciences ,viruses ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,fungi ,respiratory system ,010501 environmental sciences ,complex mixtures ,01 natural sciences ,Pollution ,Virology ,Aerosol ,law.invention ,Transmission (mechanics) ,law ,Environmental Chemistry ,Environmental science ,General Materials Science ,skin and connective tissue diseases ,Aerosol sampling ,0105 earth and related environmental sciences - Abstract
To assess the risk of aerosol transmission of SARS-CoV-2, measurements of the airborne viral concentrations in proximity to infected individuals, the persistence of the virus in aerosols, and the d...
- Published
- 2021
18. Simulating Convective GWs forced by Radar-Based, Neural-Network-Predicted Diabatic Heating
- Author
-
Christopher Kruse, M. Joan Alexander, Martina Bramberger, Padram Hassanzadeh, Ashesh Chattopadhyay, Brian Green, and Alison Grimsdell
- Abstract
Convection, both observed and modeled, generates gravity waves (GWs) that significantly impact large-scale circulations in the stratosphere and above. However, models that permit convection and resolve the GWs they generate cannot reproduce the timing, location, and intensity of the actual convective cells that generate the observed convective GWs. This issue prevents comparison of observed and modeled convective GWs and model validation/evaluation. Here, convective latent heating is predicted based on radar observations and provided to an idealized version of WRF, allowing WRF’s dynamics to generate convective updrafts/downdrafts and generated convective GWs both mechanically and diabatically. Two methods are used to predict convective latent heating: the composited lookup table of Bramberger et al. 2020 and neural networks (NNs) using the same, and additional, input variables. Offline performance of the NN-predicted latent heating can be improved over the previous method when more input variables are used. Preliminary comparisons of modeled and observed (via superpressure-balloon and satellite) convective GWs will be presented.
- Published
- 2022
19. Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trialResearch in context
- Author
-
Teresa H. Evering, Carlee Moser, Nikolaus Jilg, Justin Ritz, David A. Wohl, Jonathan Z. Li, David Margolis, Arzhang Cyrus Javan, Joseph J. Eron, Judith S. Currier, Eric S. Daar, Davey M. Smith, Michael D. Hughes, Kara W. Chew, Kara Chew, David (Davey) Smith, Eric Daar, David Wohl, Judith Currier, Joseph Eron, Michael Hughes, Mark Giganti, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott Sieg, Jonathan Li, Courtney Fletcher, William Fischer, Rachel Bender Ignacio, Sandra Cardoso, Katya Corado, Prasanna Jagannathan, Alan Perelson, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi, Verónica Lacal, Diego Salusso, Sebastian Nuñez, Marcelo Rodrigo Rodriguez, Luciana Laborde, Marcelo Papasidero, Luis Wehbe, Mariana Gonzalez, Felicitas Fernandez Voena, Tomas Alvarez, Amaru Lopez, Virginia Huhn, Ulises D'Andrea Nores, Pablo Dieser, Fernando Bordese, Marisa Mussi, Rodrigo de Carvalho Santana, Adriana Aparecida Tiraboschi Bárbaro, Breno Santos, Rita de Cássia Alves Lira, Andre Luiz Machado da Silva, Sandra Wagner Cardoso, Maria Pia Diniz Ribeiro, Nathália Soliva, Eduardo Vasconcellos, Jorge Eurico Ribeiro, Miriam Amaral Enéas, Jorge Pinto, Julia Fonseca de Morais Caporali, Flávia Gomes Faleiro Ferreira, Norma Erendira Rivera Martinez, Victor Casildo Bohorquez Lopez, Melchor Victor Frias, Krystle Fetalvero, Alyxzza Maranan, Jennifer Rosa, Thomas Coetzer, Maureen Mohata, Sr., Umesh Lalloo, Penelope Madlala, Larisha Pillay-Ramaya, Jaclyn Ann Bennet, Noluthando Mwelase, Nokuphiwa Mbhele, Frederick Petrick, Leonard Joubert, Rose Mbali, Sr., Natasha Joseph, Mmatsie Manentsa, Eugene van der Walt, Mduduzi Sandile Lawrance Masilela, Zinhle Zwane, Tendai Chiperera, Lerato Mohapi, Suri Moonsamy, Usha Singh, Kirsten McHarry, Elizma Snyman, Pieter Lennox, James Craig Innes, Oteng Letlape, Olebogeng Jonkane, William Brumskine, Tania Adonis, Ni Ni Sein, Modulakgotla Sebe, Yacoob Vahed, Nazreen Jeewa Hussen, Ismail Mitha, Vasundhara Cheekati, Purna Cheekati, Christie Lummus, Samuel Idarraga, Andrew Kim, David N. Pham, Wei-Hsin Kao, Michael M. Pfeffer, Miriam Batule Dominguez, Anju Malik, Anna Bryan, Melanie Arnold, Idania Fernandez, Cinzia Karpf, Aniuska Ruiz, David Taylor, Eric Folkens, Jennifer Manne, Sigal Yawetz, Cheryl Keenan, Emeka Eziri, Carl Fichtenbaum, Jenifer Baer, Sarah Trentman, Robert Call, Leroy Vaughan, Aaron Milstone, Jamie Alex Slandzicki, Jessica Wallan, Clinton Guillory, Nancy Andrews, Leslie Hughes, Jonathan Berardi, Celine Arar, Randall Quinn, Jorge P. Amaya, Marissa Gomez-Martinez, Luis Cantu, Monica Betancourt-Garcia, Nwora Lance Okeke, Charles M. Burns, Fadi Haddad, Victoria Haddad, Augusto Focil, Griselda Rosas, Susana Moyano, Yaneicy Gonzalez Rojas, Ahmad Aswad, Yevgeniy Bukhman, Manish Jain, Eugene Bukhman, Humam Farah, Rebekah McClain, Sadia Shaik, Timothy Hatlen, Deepa Gotur, Joseph Surber, Jeffrey Kingsley, April Pixler, Alex Zopo, Jack Herman, Craig Herman, Ramon Leon, Boris Nikolov, Fernando Gonzalez Vergara, Ana I. Gonzalez, Noemi Gonzalez, Michael Gelman, Olga Andriunas, Zarema Jagizarov, Jan Westerman, David Davis, Donna Sherer, Kelly Dooley, Becky Becker, Adaliah Wilkins, Jose Pérez, Eloy Roman, Heriberto Fernández, Bharat Mocherla, Kelly Beck, Valarie Maldonado, Jennifer Veltman, Rajesh Gandhi, Katrina Shea, Matthew Planchon, Laura Bogan Herpel, Kaushlendra K. Tripathi, Donald C. Day, John Pullman, Sr., Erin Williams-Leber, Misty Johnson, Michelle Hecker, Ann Avery, Keila Hoover, George W. Monlux, Elizabeth Juneja, Jr., Arthur Wernick, Karelia Ruiz, Maureen Hernández, Yadilys Pérez, Babafemi O. Taiwo, Claudia Hawkins, Baiba Berzins, Carlos Malvestutto, Heather Harber, Robyn Cicarella, Edwin DeJesus, Charlotte-Paige Rolle, Almena L. Free, Sallie D. Pulliam, Debra Weinstein, Rosa M. Suarez, Ezequiel Socorro, Estefania Socorro, Gene Neytman, Raymond Easley, Mariam Aziz, Joan Swiatek, Avish Nagpal, Breanna Kompelien, Kathryn McEvoy, Susan E. Hoover, Allison Lutz, Jessica Just, Manuel Hernandez, Yanly B. Victoria, Gabriel Rodriguez, Divya Pathak, Joshua J. Ordway, Megan Heffner, Patrick Weston, Khalilah Weston, Madhu Choudhary, Jennifer Sullivano, Olayemi Osiyemi, Myriam Izquierdo, Odelsey Torna, Brian Clemency, Renoj Varughese, Joshua Lynch, Aleen Khodabakhshian, Samantha Fortier, Christopher Coyne, Alexandrea Cronin, Constance Benson, Steven Hendrickx, Rosemarie Ramirez, Anne Luetkemeyer, Suzanne Hendler, Dennis Dentoni-Lasofsky, Mobeen Rathore, Saniyyah Mahmoudi, Amna Riaz, Mario Castro, Leslie Spikes, Chase Hall, Jonathan Oakes, Amy James Loftis, Pablo Tebas, William Short, Michael P. Dube, Saahir Khan, Luis M. Mendez, Sarah McGuffin, Chris Jonsson, Mamta K. Jain, Smruthi Senthil, Kimberly Turner-Gray, Sanjay Mehta, Mary Lewinski, Masoud Azizad, Christopher Chow, Lisa Nakatani, Derrick Williamson, Hisham Atriss, Matthew Caloura, Midhun Malla, Hannah Hazard-Jenkins, Aimee Wilkin, Jamraus Fayssoux, Hannah Seagle, Rachel Presti, and Alem Haile
- Subjects
COVID-19 ,Monoclonal antibodies ,Outpatient treatment ,Clinical trial ,Post COVID conditions ,Long COVID ,Medicine (General) ,R5-920 - Abstract
Summary: Background: It is unknown if early COVID-19 monoclonal antibody (mAb) therapy can reduce risk of Long COVID. The mAbs amubarvimab/romlusevimab were previously demonstrated to reduce risk of hospitalization/death by 79%. This study assessed the impact of amubarvimab/romlusevimab on late outcomes, including Long COVID. Methods: Non-hospitalized high-risk adults within 10 days of COVID-19 symptom onset enrolled in a randomized, double-blind, placebo-controlled phase 2/3 trial of amubarvimab/romlusevimab for COVID-19 treatment. Late symptoms, assessed using a participant-completed symptom diary, were a pre-specified exploratory endpoint. The primary outcome for this analysis was the composite of Long COVID by participant self-report (presence of COVID-19 symptoms as recorded in the diary at week 36) or hospitalization or death by week 36. Inverse probability weighting (IPW) was used to address incomplete outcome ascertainment, giving weighted risk ratios (wRR) comparing amubarvimab/romlusevimab to placebo. Findings: Participants received amubarvimab/romlusevimab (n = 390) or placebo (n = 390) between January and July 2021. Median age was 49 years, 52% were female, 18% Black/African American, 49% Hispanic/Latino, and 9% COVID-19-vaccinated at entry. At week 36, 103 (13%) had incomplete outcome ascertainment, and 66 (17%) on amubarvimab/romlusevimab and 92 (24%) on placebo met the primary outcome (wRR = 0.70, 95% confidence interval (CI) 0.53–0.93). The difference was driven by fewer hospitalizations/deaths with amubarvimab/romlusevimab (4%) than placebo (13%). Among 652 participants with available diary responses, 53 (16%) on amubarvimab/romlusevimab and 44 (14%) on placebo reported presence of Long COVID. Interpretation: Amubarvimab/romlusevimab treatment, while highly effective in preventing hospitalizations/deaths, did not reduce risk of Long COVID. Additional interventions are needed to prevent Long COVID. Funding: National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Amubarvimab and romlusevimab supplied by Brii Biosciences.
- Published
- 2024
- Full Text
- View/download PDF
20. Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
- Author
-
Paul A. Dabisch, Michael Schuit, Idris Hooper, Brian Holland, Denise Freeburger, Jason Yolitz, Brian Green, John J. Yeager, Stewart Wood, Victoria Wahl, Louis A. Altamura, Jeremy A. Boydston, Shanna Ratnesar-Shumate, Jordan Bohannon, Michael Hevey, Jennifer Biryukov, Gregory Williams, Melissa Krause, and Katie Beck
- Subjects
Sunlight ,2019-20 coronavirus outbreak ,environmental persistence ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,Ultraviolet Rays ,Chemistry ,Disinfectant ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,fungi ,COVID-19 ,AcademicSubjects/MED00290 ,Infectious Diseases ,Sars virus ,Major Article ,Humans ,Immunology and Allergy ,AcademicSubjects/MED00860 ,Food science ,skin and connective tissue diseases ,Coronavirus Infections ,Infectious virus - Abstract
Previous studies have demonstrated that SARS-CoV-2 is stable on surfaces for extended periods under indoor conditions. In the present study, simulated sunlight rapidly inactivated SARS-CoV-2 suspended in either simulated saliva or culture media and dried on stainless steel coupons. Ninety percent of infectious virus was inactivated every 6.8 minutes in simulated saliva and every 14.3 minutes in culture media when exposed to simulated sunlight representative of the summer solstice at 40°N latitude at sea level on a clear day. Significant inactivation also occurred, albeit at a slower rate, under lower simulated sunlight levels. The present study provides the first evidence that sunlight may rapidly inactivate SARS-CoV-2 on surfaces, suggesting that persistence, and subsequently exposure risk, may vary significantly between indoor and outdoor environments. Additionally, these data indicate that natural sunlight may be effective as a disinfectant for contaminated nonporous materials., This study provides the first evidence that sunlight may rapidly inactivate SARS-CoV-2 on surfaces, suggesting that persistence, and subsequently exposure risk, may vary significantly between indoor and outdoor environments.
- Published
- 2020
21. Efficacy of pediatric dermatology Extension for Community Healthcare Outcomes (ECHO) sessions on augmenting primary care providers' confidence and abilities
- Author
-
Haorui Sun, Brian Green, Andrea Zaenglein, Melissa Butt, Joslyn S. Kirby, and Alexandra Flamm
- Subjects
Primary Health Care ,Surveys and Questionnaires ,Pediatrics, Perinatology and Child Health ,Humans ,Community Health Services ,Dermatology ,Child - Abstract
Due to the shortage of pediatric dermatologists and the abundance of skin disorders presenting in childhood, general pediatricians shoulder the management of many pediatric dermatologic disorders and would benefit from additional dermatology-specific training. To address this educational gap, general pediatricians were enrolled in a pediatric dermatology-specific Project Extension for Community Healthcare Outcomes (ECHO) program and surveyed to assess the efficacy of the program in increasing providers' ability and confidence in managing pediatric dermatologic conditions. Providers unanimously reported increased confidence and abilities in assessment and management of pediatric dermatologic conditions. Pediatric dermatology Project ECHO demonstrated high efficacy in improving general practitioners' comfort and knowledge on dermatology-specific topics and may be used as an education model for enhancing primary care providers' knowledge and management of common disorders.
- Published
- 2021
22. P-P13 Long-term outcome after portal vein resection during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matched analysis
- Author
-
James Russell, Claire Stevens, Rahul Bhome, Dimitrios Karavias, Ali Arshad, Arjun Takhar, Thomas Armstrong, John Primrose, Brian Green, and Zaed Hamady
- Subjects
Surgery - Abstract
Background Portal vein resection (PVR) with pancreaticoduodenectomy (PD) is often performed to achieve clear margins for patients with vascular involvement in pancreatic ductal adenocarcinoma (PDAC). However, there is evidence to suggest that patients undergoing PVR often have more advanced cancers, therefore the impact of PVR on survival and recurrence remains unclear. The aim of this study is to assess overall (OS) and recurrence free (RFS) survival in patients who underwent PVR during PD, with particular attention to margin positivity. Methods A retrospective analysis was performed on 638 patients who underwent PD during a 12-year period. Exclusion criteria included PD for non-PDAC tumours, neoadjuvant chemotherapy or intra-operative radiotherapy. 374 patients were included in the study (90 PVR and 284 non-PVR). Patient characteristics and histopathological factors associated with OS and RFS were then evaluated using univariate and multivariate Cox regression analyses. 270 patients (90 PVR and 180 non-PVR), were matched by propensity score based on perineural invasion, pT and pN staging. The Kaplan-Meier method was used to calculate survival and log-rank tests. Results Resection margin positivity was associated with shorter OS and RFS (p Conclusions Positive resection margins are associated with shorter survival times, and the SMV margin is the most significant prognostic indicator for overall survival and recurrence compared to other margins. PVR is a relatively safe procedure, however, it does not achieve the intended survival benefits of complete margin clearance. The impact on survival for margin positivity, particularly the SMV margin, and nodal metastasis should be considered when making decisions with regards to vein resection and adjuvant treatments.
- Published
- 2021
23. ONIX for licensing terms: Standards for the electronic communication of usage terms.
- Author
-
Brian Green, David Martin, and Francis Cave
- Published
- 2007
- Full Text
- View/download PDF
24. Seroconversion and fever are dose-dependent in a nonhuman primate model of inhalational COVID-19
- Author
-
Michael Winpigler, Michael Hevey, James H. Miller, Tina Sweeney, Jeremy A. Boydston, Paul A. Dabisch, Amy L. Reese, Tammy Jenkins, Susan E. Miller, Sherry Rippeon, Artemas Herzog, Jennifer Biryukov, Owen Price, Ashley Patty, Victoria Wahl, Kim Rhodes, Jason Rodriguez, Jordan Bohannon, Jaleal S Sanjak, Louis A. Altamura, Brian Green, David Miller, Brian Holland, Denise Freeburger, Alec S Hail, Gregory Williams, Emmanuel Manan, Heather Zimmerman, Katie Beck, John J. Yeager, and David Clarke
- Subjects
RNA viruses ,Viral Diseases ,Pulmonology ,Coronaviruses ,Physiology ,Fevers ,Disease ,Monkeys ,Body Temperature ,Medical Conditions ,Medicine and Health Sciences ,Young adult ,Biology (General) ,Materials ,Pathology and laboratory medicine ,Inhalation exposure ,Mammals ,Transmission (medicine) ,Infectious dose ,Eukaryota ,Medical microbiology ,Infectious Diseases ,Physiological Parameters ,Viruses ,Physical Sciences ,Vertebrates ,medicine.symptom ,SARS CoV 2 ,Pathogens ,Viral load ,Macaque ,Research Article ,Primates ,SARS coronavirus ,QH301-705.5 ,Immunology ,Materials Science ,Asymptomatic ,Microbiology ,Respiratory Disorders ,Signs and Symptoms ,Virology ,Old World monkeys ,Genetics ,medicine ,Animals ,Humans ,Seroconversion ,Molecular Biology ,Aerosols ,Biology and life sciences ,business.industry ,SARS-CoV-2 ,Organisms ,Viral pathogens ,COVID-19 ,Covid 19 ,RC581-607 ,Microbial pathogens ,Mixtures ,Respiratory Infections ,Amniotes ,Parasitology ,Immunologic diseases. Allergy ,Clinical Medicine ,business ,Zoology - Abstract
While evidence exists supporting the potential for aerosol transmission of SARS-CoV-2, the infectious dose by inhalation remains unknown. In the present study, the probability of infection following inhalation of SARS-CoV-2 was dose-dependent in a nonhuman primate model of inhalational COVID-19. The median infectious dose, assessed by seroconversion, was 52 TCID50 (95% CI: 23–363 TCID50), and was significantly lower than the median dose for fever (256 TCID50, 95% CI: 102–603 TCID50), resulting in a group of animals that developed an immune response post-exposure but did not develop fever or other clinical signs of infection. In a subset of these animals, virus was detected in nasopharyngeal and/or oropharyngeal swabs, suggesting that infected animals without signs of disease are able to shed virus and may be infectious, which is consistent with reports of asymptomatic spread in human cases of COVID-19. These results suggest that differences in exposure dose may be a factor influencing disease presentation in humans, and reinforce the importance of public health measures that limit exposure dose, such as social distancing, masking, and increased ventilation. The dose-response data provided by this study are important to inform disease transmission and hazard modeling, and, ultimately, mitigation strategies. Additionally, these data will be useful to inform dose selection in future studies examining the efficacy of therapeutics and vaccines against inhalational COVID-19, and as a baseline in healthy, young adult animals for assessment of the importance of other factors, such as age, comorbidities, and viral variant, on the infectious dose and disease presentation., Author summary SARS-CoV-2 infection and subsequent disease presentation are dependent on exposure dose in a nonhuman primate model of inhalational COVID-19.
- Published
- 2021
25. Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan
- Author
-
Grant A. Mackenzie, Isaac Osei, Rasheed Salaudeen, Paul V. Licciardi, Brian Greenwood, Kim Mulholland, and Cattram Nguyen
- Subjects
Pneumococcal ,Vaccine ,Schedule ,Cluster-randomised controlled trial ,Statistical analysis ,Immunogenicity ,Medicine (General) ,R5-920 - Abstract
Abstract Rationale The effectiveness of immunisation with pneumococcal conjugate vaccine (PCV) has been demonstrated in many countries. However, the global impact of PCV is limited by its cost, which has prevented its introduction in some countries. Reducing the cost of PCV programmes will facilitate further vaccine introductions and improve the sustainability of PCV in low-income countries when they transition from subsidised vaccine supply. We are conducting a large, population-level, cluster-randomised field trial (PVS) of an alternative reduced-dose schedule of PCV compared to the standard schedule. We are also conducting a nested sub-study at the individual level to investigate the immunogenicity of the two schedules and their effects on pneumococcal carriage acquisition (PVS-AcqImm). Methods and design PVS-AcqImm is a prospective, cluster-randomised trial of an alternative schedule of one dose of PCV scheduled at age 6 weeks with a booster dose at age 9 months compared to the standard of three primary doses scheduled at 6, 10, and 14 weeks of age. Sub-groups within the alternative schedule group receive yellow fever vaccine separately or co-administered with PCV at 9 months of age. The primary endpoints are (a) concentrations of vaccine-type anti-pneumococcal IgG at 18 months of age, (b) proportions with yellow fever neutralising antibody titre ≥ 1:8 4 weeks after separate or co-administration of PCV and yellow fever vaccines, and (c) rate of nasopharyngeal vaccine-type pneumococcal acquisition from 10–14 months of age. Participants and field staff are not masked to group allocation while measurement of the laboratory endpoints is masked. Approximately equal numbers of participants are resident in each of 28 randomly allocated geographic clusters (14 clusters in each group); 784 enrolled for acquisition measurements and 336 for immunogenicity measurements. Purpose This statistical analysis plan (SAP) describes the PVS-AcqImm cohort and follow-up criteria to be used in different analyses. The SAP defines the endpoints and describes how adherence to the interventions will be presented. We describe the approach to analyses and how we will account for the effect of clustering. Defining the SAP prior to the conduct of analysis will avoid bias in analyses that may arise from prior knowledge of trial findings. Trial registration ISRCTN, ISRCTN7282161328. Registered on 28 November 2019. https://www.isrctn.com/ISRCTN72821613 . Protocol: MRCG SCC number 1670, LSHTM Ref 17683. Current protocol version: 6.0, 24 May 2021. Version: 1.0 (5 April 2023); SAP revisions—none.
- Published
- 2024
- Full Text
- View/download PDF
26. Engaging the public in decisions about emergency vaccine deployment strategies: Lessons from scenario-based discussions in Sierra Leone
- Author
-
Anthony Mansaray, Mahmood Bangura, Deborah Watson-Jones, Brian Greenwood, Rose Burns, Shelley Susan Lees, Farba Faye, Bailah Leigh, and Luisa Enria
- Subjects
Emergency ,Vaccine ,Deployment ,Community engagement ,Sierra Leone ,Public aspects of medicine ,RA1-1270 - Abstract
ABSTRACTThe COVID-19 pandemic has amplified discussions on emergency vaccine deployment strategies, with current perspectives often neglecting extensive community involvement in ethical, logistical and political aspects. Existing social science literature predominantly delves into factors influencing trust, overlooking the untapped potential for community engagement.Our study examines community preparedness in Sierra Leone’s Kambia District, exploring diverse viewpoints on vaccine deployment strategies, emphasising Ebola and COVID-19 vaccinations. Utilising extensive ethnographic research from the Ebola vaccine trials (EBOVAC Salone) conducted in Kambia District from 2015 to 2021, including participant observation and tailored focus group discussions, we investigated various deployment scenarios with community leaders and citizens.Our findings underscore the multifaceted contributions of social science research with communities in shaping emergency vaccination strategies. These contributions span logistical insights, aligning campaigns with local livelihoods and social structures, and grounded ethical concerns assessing social justice outcomes across epidemic scenarios. This study emphasises the imperative of integrating discussions on vaccine confidence and deployment. It highlights communities’ proficiency in epidemiological reasoning and their ability to bring this in conversation with salient socio-cultural, economic and religious dimensions. We therefore promote the cultivation of public dialogue, collaborative creation of impactful vaccination initiatives alongside relevant communities in recognition of their invaluable perspectives .
- Published
- 2024
- Full Text
- View/download PDF
27. Modulation of Monsoon Circulations by Cross-Equatorial Ocean Heat Transport
- Author
-
Nicholas J. Lutsko, Brian Green, and John Marshall
- Subjects
Atmospheric Science ,Indian ocean ,Modulation ,Climatology ,Monsoon ,Geology ,Energy transport - Abstract
Motivated by observations of southward ocean heat transport (OHT) in the northern Indian Ocean during summer, the role of the ocean in modulating monsoon circulations is explored by coupling an atmospheric model to a slab ocean with an interactive representation of OHT and an idealized subtropical continent. Southward OHT by the cross-equatorial cells is caused by Ekman flow driven by southwesterly monsoon winds in the summer months, cooling sea surface temperatures (SSTs) south of the continent. This increases the reversed meridional surface gradient of moist static energy, shifting the precipitation maximum over the land and strengthening the monsoonal circulation, in the sense of enhancing the vertical wind shear. However, the atmosphere’s cross-equatorial meridional overturning circulation is also weakened by the presence of southward OHT, as the atmosphere is required to transport less energy across the equator. The sensitivity of these effects to varying the strength of the OHT, fixing the OHT at its annual-mean value, and to removing the land is explored. Comparisons with more realistic models suggest that the idealized model used in this study produces a reasonable representation of the effect of OHT on SSTs equatorward of subtropical continents, and hence can be used to study the role of OHT in shaping monsoon circulations on Earth.
- Published
- 2019
28. Patient satisfaction of real-time teledermatology: a cross-sectional survey
- Author
-
Brian Green, Matthew F. Helm, Abigail Washington, Melissa Butt, Bryan Moore, and Colleen Silva
- Subjects
Teledermatology ,medicine.medical_specialty ,business.industry ,Cross-sectional study ,Dermatology ,Skin Diseases ,Telemedicine ,Patient satisfaction ,Cross-Sectional Studies ,Patient Satisfaction ,Family medicine ,Medicine ,Humans ,business - Published
- 2021
29. Cell wall protein variation, break-induced replication, and subtelomere dynamics in Candida glabrata
- Author
-
Nicole Benoit, Brendan P. Cormack, Sarah J. Wheelan, Jack D. Sobel, Zhuwei Xu, Michael C. Schatz, and Brian Green
- Subjects
Sequence assembly ,Candida glabrata ,Chromosomal rearrangement ,Microbiology ,Genome ,Polymorphism, Single Nucleotide ,03 medical and health sciences ,Tandem repeat ,Gene Expression Regulation, Fungal ,Cell Adhesion ,Humans ,Copy-number variation ,Molecular Biology ,Gene ,030304 developmental biology ,Genetics ,Recombination, Genetic ,0303 health sciences ,biology ,030306 microbiology ,Candidiasis ,Telomere ,Subtelomere ,biology.organism_classification ,Genome, Fungal ,Cell Adhesion Molecules - Abstract
Candida glabrata is an opportunistic pathogen of humans, responsible for up to 30% of disseminated candidiasis. Adherence of C. glabrata to host cells is mediated by adhesin-like proteins (ALPs), about half of which are encoded in the subtelomeres. We performed a de novo assembly of two C. glabrata strains, BG2 and BG3993, using long single-molecule real-time (SMRT) reads, and constructed high-quality telomere-to-telomere assemblies of all 13 chromosomes to assess differences between C. glabrata strains. We documented variation between strains, and in agreement with earlier studies, found high (~0.5%-1%) frequencies of SNVs across the genome, including within subtelomeric regions. We documented changes in ALP gene structure and complement: there are large length differences in ALP genes in different strains, resulting from copy number variation in tandem repeats. We compared strains to characterize chromosome rearrangement events including within the poorly characterized subtelomeric regions. We show that rearrangements within the subtelomere regions all affect ALP-encoding genes, and 14/16 involve just the most terminal ALP gene. We present evidence that these rearrangements are mediated by break-induced replication. This study highlights the constrained nature of subtelomeric changes impacting ALP gene complement and subtelomere structure.
- Published
- 2021
30. The influence of temperature, humidity, and simulated sunlight on the infectivity of SARS-CoV-2 in aerosols
- Author
-
Brian Green, Jason Yolitz, Melissa Krause, Katie Beck, Wade Weaver, Michael Hevey, Jordan Bohannon, David Miller, Denise Freeburger, Gregory Williams, Artemas Herzog, Paul A. Dabisch, Michael Schuit, Stewart Wood, Victoria Wahl, Idris Hooper, Brian Holland, and Shanna Ratnesar-Shumate
- Subjects
Sunlight ,Infectivity ,2019-20 coronavirus outbreak ,010504 meteorology & atmospheric sciences ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Humidity ,respiratory system ,010501 environmental sciences ,Biology ,01 natural sciences ,Virology ,Pollution ,Pandemic ,Environmental Chemistry ,General Materials Science ,0105 earth and related environmental sciences - Abstract
Recent evidence suggests that respiratory aerosols may play a role in the spread of SARS-CoV-2 during the ongoing COVID-19 pandemic. Our laboratory has previously demonstrated that simulated sunlig...
- Published
- 2020
- Full Text
- View/download PDF
31. Long-term outcome after portal vein resection during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matched analysis
- Author
-
James Russell, Claire Stevens, Rahul Bhome, Dmitrios Karavias, Ali Arshad, Arjun Takhar, Thomas Armstrong, John Primrose, Brian Green, and Zaed Hamady
- Subjects
Oncology ,Surgery ,General Medicine - Published
- 2022
32. Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trial
- Author
-
Muhammed O. Afolabi, Doudou Sow, Schadrac C. Agbla, El Hadji Babacar Fall, Fatimata Bintou Sall, Amadou Seck, Isaac Akhénaton Manga, Ibrahima Marietou Mbaye, Mor Absa Loum, Baba Camara, Diatou Niang, Babacar Gueye, Doudou Sene, Ndéye M’backé Kane, Boubacar Diop, Awa Diouf, Ndéye Aida Gaye, Marie Pierre Diouf, Aminata Colle Lo, Brian Greenwood, and Jean Louis A. Ndiaye
- Subjects
Falciparum malaria ,Soil-transmitted helminthiasis ,Schistosomiasis ,Co-infection ,Integrated control strategy ,Arctic medicine. Tropical medicine ,RC955-962 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The overlap in the epidemiology of malaria and helminths has been identified as a potential area to exploit for the development of an integrated control strategy that may help to achieve elimination of malaria and helminths. A randomized, controlled, observer-blind trial was conducted to assess the feasibility and safety of combining mass drug administration (MDA) for schistosomiasis and soil transmitted helminths (STH) with seasonal malaria chemoprevention (SMC) among children living in Senegal. Methods Female and male children aged 1–14 years were randomized 1:1:1, to receive Vitamin A and Zinc on Day 0, followed by SMC drugs (sulfadoxine-pyrimethamine and amodiaquine) on Days 1–3 (control group); or praziquantel and Vitamin A on Day 0, followed by SMC drugs on Days 1–3 (treatment group 1); or albendazole and praziquantel on Day 0, followed by SMC drugs on Days 1–3 (treatment group 2). Safety assessment was performed by collecting adverse events from all children for six subsequent days following administration of the study drugs. Pre- and post-intervention, blood samples were collected for determination of haemoglobin concentration, malaria microscopy, and PCR assays. Stool samples were analyzed using Kato-Katz, Merthiolate-iodine-formalin and PCR methods. Urine filtration, PCR and circulating cathodic antigen tests were also performed. Results From 9 to 22 June 2022, 627 children aged 1–14 years were randomized into the three groups described above. Mild, transient vomiting was observed in 12.6% (26/206) of children in treatment group 2, in 10.6% (22/207) in group 1, and in 4.2% (9/214) in the control group (p = 0.005). Pre-intervention, the geometric mean value of Plasmodium falciparum parasite density was highest among children who received albendazole, praziquantel with SMC drugs. Post-intervention, the parasite density was highest among children who received SMC drugs only. Children who received praziquantel and SMC drugs had a lower risk of developing severe anaemia than their counterparts who received SMC drugs alone (OR = 0.81, 95% CI 0.13–5.00, p = 0.63). Conclusions Integration of MDA for helminths with SMC drugs was safe and feasible among Senegalese children. These findings support further evaluation of the integrated control model. Trial registration: The study is registered at Clinical Trial.gov NCT05354258.
- Published
- 2023
- Full Text
- View/download PDF
33. Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight
- Author
-
Michael Schuit, Stewart Wood, Katie Beck, Louis A. Altamura, Paul A. Dabisch, Idris Hooper, Brian Holland, Michael Hevey, Brian Green, Shanna Ratnesar-Shumate, David Miller, Jordan Bohannon, Victoria Wahl, Melissa Krause, Jason Yolitz, Jennifer Biryukov, Denise Freeburger, Wade Weaver, and Gregory Williams
- Subjects
Sunlight ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Late winter ,Humidity ,COVID-19 ,relative humidity ,Aerosol ,Animal science ,Infectious Diseases ,AcademicSubjects/MED00290 ,aerosol decay ,Major Article ,Environmental science ,Immunology and Allergy ,Relative humidity ,AcademicSubjects/MED00860 ,sunlight ,aerosol persistence - Abstract
Aerosols represent a potential transmission route of COVID-19. This study examined effect of simulated sunlight, relative humidity, and suspension matrix on stability of SARS-CoV-2 in aerosols. Simulated sunlight and matrix significantly affected decay rate of the virus. Relative humidity alone did not affect the decay rate; however, minor interactions between relative humidity and other factors were observed. Mean decay rates (± SD) in simulated saliva, under simulated sunlight levels representative of late winter/early fall and summer were 0.121 ± 0.017 min−1 (90% loss, 19 minutes) and 0.306 ± 0.097 min−1 (90% loss, 8 minutes), respectively. Mean decay rate without simulated sunlight across all relative humidity levels was 0.008 ± 0.011 min−1 (90% loss, 286 minutes). These results suggest that the potential for aerosol transmission of SARS-CoV-2 may be dependent on environmental conditions, particularly sunlight. These data may be useful to inform mitigation strategies to minimize the potential for aerosol transmission.
- Published
- 2020
34. Hemispherically asymmetric trade wind changes as signatures of past ITCZ shifts
- Author
-
Eric D. Galbraith, John Marshall, Louisa I Bradtmiller, Eduardo Moreno-Chamarro, Brian Green, and David McGee
- Subjects
Archeology ,Global and Planetary Change ,010504 meteorology & atmospheric sciences ,Atmospheric circulation ,Intertropical Convergence Zone ,Ocean current ,Tropics ,Northern Hemisphere ,Global ,Geology ,Climate dynamics ,010502 geochemistry & geophysics ,01 natural sciences ,Quaternary ,Climatology ,Heinrich stadials ,Upwelling ,Climate model ,Hadley cell ,Hadley circulation ,Southern Hemisphere ,Ecology, Evolution, Behavior and Systematics ,ITCZ ,0105 earth and related environmental sciences - Abstract
The atmospheric Hadley cells, which meet at the Intertropical Convergence Zone (ITCZ), play critical roles in transporting heat, driving ocean circulation and supplying precipitation to the most heavily populated regions of the globe. Paleo-reconstructions can provide concrete evidence of how these major features of the atmospheric circulation can change in response to climate perturbations. While most such reconstructions have focused on ITCZ-related rainfall, here we show that trade wind proxies can document dynamical aspects of meridional ITCZ shifts. Theoretical expectations based on angular momentum constraints and results from freshwater hosing simulations with two different climate models predict that ITCZ shifts due to anomalous cooling of one hemisphere would be accompanied by a strengthening of the Hadley cell and trade winds in the colder hemisphere, with an opposite response in the warmer hemisphere. This expectation of hemispherically asymmetric trade wind changes is confirmed by proxy data of coastal upwelling and windblown dust from the Atlantic basin during Heinrich stadials, showing trade wind strengthening in the Northern Hemisphere and weakening in the Southern Hemisphere subtropics in concert with southward ITCZ shifts. Data from other basins show broadly similar patterns, though improved constraints on past trade wind changes are needed outside the Atlantic Basin. The asymmetric trade wind changes identified here suggest that ITCZ shifts are also marked by intensification of the ocean's wind-driven subtropical cells in the cooler hemisphere and a weakening in the warmer hemisphere, which induces cross-equatorial oceanic heat transport into the colder hemisphere. This response would be expected to prevent extreme meridional ITCZ shifts in response to asymmetric heating or cooling. Understanding trade wind changes and their coupling to cross-equatorial ocean cells is key to better constraining ITCZ shifts and ocean and atmosphere dynamical changes in the past, especially for regions and time periods for which few paleodata exist, and also improves our understanding of what changes may occur in the future.
- Published
- 2018
35. Multi-layer longitudinally specular optics for distributing diffuse light
- Author
-
Sadlik Bram M, Kent Coulter, Brian Green, Lorne A. Whitehead, and John M. Tamkin
- Subjects
Optics ,Materials science ,business.industry ,Diffuse reflection ,Specular reflection ,Electrical and Electronic Engineering ,business ,Engineering (miscellaneous) ,Multi layer ,Atomic and Molecular Physics, and Optics - Abstract
Multi-layer optical thin films can reflect light to guide it along a hollow tube that they internally line. However, reflecting broadband white light for a range of angles requires many precise thin optical layers, which can be too expensive for large-scale applications such as architectural illumination. Here, we present an alternative configuration that requires only one readily achievable aspect of precision—having a substantially constant cross section, perpendicular to the planned longitudinal propagation direction. This aspect conserves a light ray’s longitudinal directional component, while the ray’s path in the perpendicular direction can be macroscopically chaotic, much like the diffuse reflection characteristic arising from many non-absorbing pigment particles. This macroscopic characteristic is described here as “longitudinally specular” and “transversely diffuse.” This new design overcomes two problems that are found with current prism light guides (PLGs), which are a class of hollow light guides that also have a constant cross section. The PLG has two problems: (1) it requires structured surfaces having near-perfect linear prisms that are much larger than the wavelength of light, wasting optical material and increasing absorption; (2) it only works well with light that has been partially collimated, which limits étendue and requires expensive, inefficient input optics. In this paper, a new, to the best of our knowledge, approach, labeled a “multi-layer prism light guide,” simultaneously addresses both problems. Although the new structure is more complex than a conventional PLG, it may be simpler to manufacture. One potential application is for guiding sunlight into buildings for illumination purposes, without requiring complex sun-tracking solar collection optics.
- Published
- 2021
36. Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.
- Author
-
Houreratou Barry, Edouard Lhomme, Mathieu Surénaud, Moumini Nouctara, Cynthia Robinson, Viki Bockstal, Innocent Valea, Serge Somda, Halidou Tinto, Nicolas Meda, Brian Greenwood, Rodolphe Thiébaut, and Christine Lacabaratz
- Subjects
Arctic medicine. Tropical medicine ,RC955-962 ,Public aspects of medicine ,RA1-1270 - Abstract
BackgroundThe exposure to parasites may influence the immune response to vaccines in endemic African countries. In this study, we aimed to assess the association between helminth exposure to the most prevalent parasitic infections, schistosomiasis, soil transmitted helminths infection and filariasis, and the Ebola virus glycoprotein (EBOV GP) antibody concentration in response to vaccination with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen in African and European participants using samples obtained from three international clinical trials.Methods/principal findingsWe conducted a study in a subset of participants in the EBL2001, EBL2002 and EBL3001 clinical trials that evaluated the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against EVD in children, adolescents and adults from the United Kingdom, France, Burkina Faso, Cote d'Ivoire, Kenya, Uganda and Sierra Leone. Immune markers of helminth exposure at baseline were evaluated by ELISA with three commercial kits which detect IgG antibodies against schistosome, filarial and Strongyloides antigens. Luminex technology was used to measure inflammatory and activation markers, and Th1/Th2/Th17 cytokines at baseline. The association between binding IgG antibodies specific to EBOV GP (measured on day 21 post-dose 2 and on Day 365 after the first dose respectively), and helminth exposure at baseline was evaluated using a multivariable linear regression model adjusted for age and study group. Seventy-eight (21.3%) of the 367 participants included in the study had at least one helminth positive ELISA test at baseline, with differences of prevalence between studies and an increased prevalence with age. The most frequently detected antibodies were those to Schistosoma mansoni (10.9%), followed by Acanthocheilonema viteae (9%) and then Strongyloides ratti (7.9%). Among the 41 immunological analytes tested, five were significantly (p < .003) lower in participants with at least one positive helminth ELISA test result: CCL2/MCP1, FGFbasic, IL-7, IL-13 and CCL11/Eotaxin compared to participants with negative helminth ELISA tests. No significant association was found with EBOV-GP specific antibody concentration at 21 days post-dose 2, or at 365 days post-dose 1, adjusted for age group, study, and the presence of any helminth antibodies at baseline.Conclusions/significanceNo clear association was found between immune markers of helminth exposure as measured by ELISA and post-vaccination response to the Ebola Ad26.ZEBOV/ MVA-BN-Filo vaccine regimen.Trial registrationNCT02416453, NCT02564523, NCT02509494. ClinicalTrials.gov.
- Published
- 2024
- Full Text
- View/download PDF
37. Twentieth century correlations between extratropical SST variability and ITCZ shifts
- Author
-
Brian Green, Aaron Donohoe, John Marshall, Massachusetts Institute of Technology. Department of Earth, Atmospheric, and Planetary Sciences, Green, Brian Marcus, and Marshall, John C
- Subjects
010504 meteorology & atmospheric sciences ,Atmospheric circulation ,Intertropical Convergence Zone ,Equator ,Ocean current ,Northern Hemisphere ,010502 geochemistry & geophysics ,01 natural sciences ,Sea surface temperature ,Geophysics ,Climatology ,Extratropical cyclone ,General Earth and Planetary Sciences ,Southern Hemisphere ,Geology ,0105 earth and related environmental sciences - Abstract
The Intertropical Convergence Zone (ITCZ) is a global-scale band of tropical precipitation lying, in the annual mean, just north of the equator. Its position can be tied to the atmosphere's energy balance: the Northern Hemisphere is heated more strongly than the Southern Hemisphere, biasing the atmosphere's circulation and ITCZ north of the equator. In the context of this energy balance framework, we examine multidecadal connections between variations in the position of the global ITCZ and indices of extratropical sea surface temperature (SST) variability over the twentieth century. We find that the ITCZ and atmospheric circulation are shifted farther to the north during periods when North Atlantic and North Pacific SSTs are anomalously warm. Additionally, a warmer North Atlantic is correlated with a relatively warm Northern Hemisphere atmosphere. Our results suggest an important role for the ocean circulation in modulating ITCZ migrations on decade-and-longer timescales., United States. National Oceanic and Atmospheric Administration
- Published
- 2017
38. Oviposition to Hatching: Development ofVaranus rosenbergi
- Author
-
Robin M. Andrews, Nadav Pezaro, J. Sean Doody, Brian Green, and Fiorenzo Guarino
- Subjects
0106 biological sciences ,0301 basic medicine ,Prolonged incubation ,biology ,Hatching ,Ecology ,media_common.quotation_subject ,Zoology ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Incubation period ,03 medical and health sciences ,030104 developmental biology ,Incubation temperature ,Animal Science and Zoology ,Varanus rosenbergi ,Reproduction ,Ecology, Evolution, Behavior and Systematics ,media_common - Abstract
Varanus rosenbergi females oviposit in nests excavated in termite mounds in summer, and hatching occurs the following spring after a seven-month incubation period. In this study, we characterized developmental features associated with the prolonged incubation of this species at Kangaroo Island in South Australia. Oviposition occurs shortly after limb buds have formed, and the subsequent pattern of organogenesis is similar to that of other lizards. Survival of eggs incubated at constant temperatures ranging from 26–33°C was 89–100%, whereas survival at 24°C and at 35°C was 0 and 14%, respectively. During the incubation period, mean ambient temperature at Kangaroo Island (14–15°C) is too low for successful reproduction, whereas mean temperatures in termite mounds (27–37°C) are substantially warmer and similar to the estimated mean incubation temperature (26–27°C). Therefore, successful reproduction by V. rosenbergi in southern Australia may be contingent on nesting in termitaria. Varanids, in gener...
- Published
- 2017
39. Coupling of Trade Winds with Ocean Circulation Damps ITCZ Shifts
- Author
-
John Marshall and Brian Green
- Subjects
Atmospheric Science ,010504 meteorology & atmospheric sciences ,Intertropical Convergence Zone ,Ocean current ,Equator ,Energy balance ,010502 geochemistry & geophysics ,Atmospheric sciences ,01 natural sciences ,Atmosphere ,Sea surface temperature ,Climatology ,Hadley cell ,Precipitation ,Physics::Atmospheric and Oceanic Physics ,Geology ,0105 earth and related environmental sciences - Abstract
The position of the intertropical convergence zone (ITCZ) is sensitive to the atmosphere’s hemispheric energy balance, lying in the hemisphere most strongly heated by radiative and turbulent surface energy fluxes. This study examines how the ocean circulation, through its cross-equatorial energy transport and associated surface energy fluxes, affects the ITCZ’s response to an imposed interhemispheric heating contrast in a coupled atmosphere–ocean general circulation model. Shifts of the ITCZ are strongly damped owing to a robust coupling between the atmosphere’s Hadley cells and the ocean’s subtropical cells by the trade winds and their associated surface stresses. An anomalous oceanic wind-driven cross-equatorial cell transports energy across the equator, strongly offsetting the imposed heating contrast. The circulation of this cell can be described by the combination of trade wind anomalies and the meridional gradient of sea surface temperature, which sets the temperature contrast between its upper and lower branches. The ability of the wind-driven ocean circulation to damp ITCZ shifts represents a previously unappreciated constraint on the atmosphere’s energy budget and indicates that the position of the ITCZ may be much less sensitive to interhemispheric heating contrasts than previously thought. Climatic implications of this damping are discussed.
- Published
- 2017
40. De novo genome assembly of Candida glabrata reveals cell wall protein complement and structure of dispersed tandem repeat arrays
- Author
-
Zhuwei Xu, Michael C. Schatz, Brendan P. Cormack, Brian Green, Nicole Benoit, and Sarah J. Wheelan
- Subjects
Glycosylphosphatidylinositols ,Sequence assembly ,Candida glabrata ,Computational biology ,Microbiology ,Genome ,03 medical and health sciences ,Open Reading Frames ,Tandem repeat ,Cell Wall ,Cell Adhesion ,Humans ,ORFS ,ORFeome ,Molecular Biology ,Gene ,030304 developmental biology ,0303 health sciences ,biology ,030306 microbiology ,Candidiasis ,High-Throughput Nucleotide Sequencing ,Membrane Proteins ,Sequence Analysis, DNA ,biology.organism_classification ,Tandem Repeat Sequences ,Genome, Fungal ,Cell Adhesion Molecules ,Reference genome - Abstract
Candida glabratais an opportunistic pathogen in humans, responsible for approximately 20% of disseminated candidiasis. Candida glabrata's ability to adhere to host tissue is mediated by GPI-anchored cell wall proteins (GPI-CWPs); the corresponding genes contain long tandem repeat regions. These repeat regions resulted in assembly errors in the reference genome. Here, we performed a de novo assembly of the C. glabrata type strain CBS138 using long single-molecule real-time reads, with short read sequences (Illumina) for refinement, and constructed telomere-to-telomere assemblies of all 13 chromosomes. Our assembly has excellent agreement overall with the current reference genome, but we made substantial corrections within tandem repeat regions. Specifically, we removed 62 genes of which 45 were scrambled due to misassembly in the reference. We annotated 31 novel ORFs of which 24 ORFs are GPI-CWPs. In addition, we corrected the tandem repeat structure of an additional 21 genes. Our corrections to the genome were substantial, with the length of new genes and tandem repeat corrections amounting to approximately 3.8% of the ORFeome length. As most corrections were within the coding regions of GPI-CWP genes, our genome assembly establishes a high-quality reference set of genes and repeat structures for the functional analysis of these cell surface proteins.
- Published
- 2019
41. Bullous systemic lupus erythematosus successfully treated with rituximab
- Author
-
Christopher D, Lowe, Catherine A, Brahe, Brian, Green, Thomas K, Lam, and Jon H, Meyerle
- Subjects
Treatment Outcome ,Adolescent ,Skin Diseases, Vesiculobullous ,Humans ,Immunologic Factors ,Lupus Erythematosus, Systemic ,Female ,Rituximab ,Skin - Abstract
Bullous systemic lupus erythematosus (BSLE) is a rare complication of systemic lupus erythematosus (SLE) characterized by cutaneous vesicles and bullae with a primarily neutrophilic infiltrate on histopathology. Bullous SLE is a heterogeneous disease without pathognomonic clinical features, making the diagnosis and differentiation from other blistering diseases challenging. We present the case of a single patient with SLE in whom 3 different clinical appearances of BSLE manifested over 5 years. The cutaneous eruption dramatically improved with rituximab at the initial presentation and continued to respond to rituximab during subsequent flares over the subsequent 5 years.
- Published
- 2019
42. The challenges of measuring British construction output
- Author
-
Brian Green
- Published
- 2019
43. Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study
- Author
-
Bolarinde J. Lawal, Katherine E. Gallagher, Jonathan Kitonsa, Daniel Tindanbil, Kambale Kasonia, Abdoulie Drammeh, Brett Lowe, Daniel Mukadi-Bamuleka, Catriona Patterson, Brian Greenwood, Mohamed Samai, Bailah Leigh, Kevin K.A. Tetteh, Eugene Ruzagira, Deborah Watson-Jones, and Hugo Kavunga-Membo
- Subjects
Seroprevalence ,Hybrid immunity ,Cross-reactivity ,SARS-CoV-2 ,Human coronaviruses ,Infectious and parasitic diseases ,RC109-216 - Abstract
Objectives: We assessed the prevalence of immunoglobulin G (IgG) and IgM against four endemic human coronaviruses and two SARS-CoV-2 antigens among vaccinated and unvaccinated staff at health care centers in Uganda, Sierra Leone, and the Democratic Republic of Congo. Methods: The government health facility staff who had patient contact in Goma (Democratic Republic of Congo), Kambia District (Sierra Leone), and Masaka District (Uganda) were enrolled. Questionnaires and blood samples were collected at three time points over 4 months. Blood samples were analyzed with the Luminex MAGPIXⓇ. Results: Among unvaccinated participants, the prevalence of IgG/IgM antibodies against SARS-CoV-2 receptor-binding domain or nucleocapsid protein at enrollment was 70% in Goma (138 of 196), 89% in Kambia (112 of 126), and 89% in Masaka (190 of 213). The IgG responses against endemic human coronaviruses at baseline were not associated with SARS-CoV-2 sero-acquisition during follow-up. Among the vaccinated participants, those who had evidence of SARS-CoV-2 IgG/IgM at baseline tended to have higher IgG responses to vaccination than those who were SARS-CoV-2 seronegative at baseline, controlling for the time of sample collection since vaccination. Conclusion: The high levels of natural immunity and hybrid immunity should be incorporated into both vaccination policies and prediction models of the impact of subsequent waves of infection in these settings.
- Published
- 2023
- Full Text
- View/download PDF
44. Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials
- Author
-
Kamija S Phiri, ProfMD PhD, Carole Khairallah, MSc, Titus K Kwambai, MD PhD, Kalifa Bojang, MD PhD, Aggrey Dhabangi, MD PhD, Robert Opoka, MD PhD, Richard Idro, MD PhD, Kasia Stepniewska, PhD, Michael Boele van Hensbroek, ProfPhD, Chandy C John, ProfPhD, Bjarne Robberstad, ProfPhD, Brian Greenwood, ProfMD, and Feiko O ter Kuile, ProfMD PhD
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: Severe anaemia is associated with high in-hospital mortality among young children. In malaria-endemic areas, surviving children also have an increased risk of mortality or readmission after hospital discharge. We conducted a systematic review and individual patient data meta-analysis to determine the efficacy of monthly post-discharge malaria chemoprevention in children recovering from severe anaemia. Methods: This analysis was conducted according to PRISMA-IPD guidelines. We searched multiple databases on Aug 28, 2023, without date or language restrictions, for randomised controlled trials comparing monthly post-discharge malaria chemoprevention with placebo or standard of care among children (aged
- Published
- 2024
- Full Text
- View/download PDF
45. How do we do more?
- Author
-
Brian Green
- Subjects
General Medicine - Published
- 2016
46. What factors are associated with paediatric admissions and their outcomes in a rural hospital in northern Sierra Leone? Insights from a pilot observational study
- Author
-
Deborah Watson-Jones, Brian Greenwood, Philip Ayieko, Bailah Leigh, Songor Koedoyoma, Muhammed Olanrewaju Afolabi, Lazarus Odeny, Gibrilla Fadlu Deen, Yusupha Njie, Hammed Hassan Adetola, Bomposseh Kamara, Abdulai Berber Jalloh, Francis Sesay, Ernest Swaray, Richmonda M Pearce, Mohamed H Samai, Isaac G Sesay, and David Ishola
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Introduction Data on the pattern of admissions and causes of child death are crucial in informing priorities for improving child survival. In many health facilities in sub-Saharan Africa, understanding the pattern of paediatric admissions and their outcomes is constrained by poor documentation of these important features.Methods We developed and piloted a simple paper-based tool for documentation of basic, standardised patient-level information on causes of admissions, diagnoses, treatments and outcomes in children admitted to a rural hospital in Sierra Leone. The tool contained sections covering basic sociodemographic information about a patient, chief medical complaints, findings from clinical examinations and tests conducted at admission, results from subsequent clinical and laboratory investigations, working/definitive diagnoses, management and treatment outcomes.Results From 1 August 2019 to 31 July 2021, we used this tool to document the admissions, treatments and clinical outcomes of 1663 children admitted to Kambia district hospital in northern Sierra Leone. The majority of the children (1015, 62%) were aged 12–59 months, were boys (942, 57%), were wasted (516, 31%), stunted (238, 14%) or underweight (537, 32%). Above a half of the children lived more than 1 km distance from the hospital (876/1410, 62%). The highest number of admissions occurred in November 2019 and the lowest in April 2020. Severe malaria was the leading cause of admission. More than 80% of the children were successfully treated and discharged home (1356/1663, 81.5%) while 122/1663 (7.3%) died. Children aged under 5 years who were underweight, and those who presented with danger signs (eg, signs of breathing difficulty, dehydration, head injury or severe infections) had a higher risk of death than children without these features (p
- Published
- 2023
- Full Text
- View/download PDF
47. Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialResearch in context
- Author
-
Prasanna Jagannathan, Kara W. Chew, Mark J. Giganti, Michael D. Hughes, Carlee Moser, Mark J. Main, Phillip D. Monk, Arzhang Cyrus Javan, Jonathan Z. Li, Courtney V. Fletcher, Caitlyn McCarthy, David A. Wohl, Eric S. Daar, Joseph J. Eron, Judith S. Currier, Upinder Singh, Davey M. Smith, William Fischer, Kara Chew, David (Davey) Smith, Eric Daar, David Wohl, Judith Currier, Joseph Eron, Michael Hughes, Mark Giganti, Justin Ritz, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott Sieg, Jonathan Li, Courtney Fletcher, Teresa Evering, Rachel Bender Ignacio, Sandra Cardoso, Katya Corado, Nikolaus Jilg, Alan Perelson, Sandy Pillay, Cynthia Riviere, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi, Gerald Pierone, Juliana Elliott, Jeffrey Jacobson, Leila Hojat, Julie Pasternak, Jonathan Berardi, Celine Arar, Yevgeniy Bukhman, Manish Jain, Eugene Bukhman, Sadia Shaik, Timothy Hatlen, Kelly Dooley, Becky Becker, Adaliah Wilkins, Jose Pérez, Eloy Roman, Heriberto Fernández, Keila Hoover, James Renfroe, Mauney Weldon, Genei Bougher, Carlos Malvestutto, Heather Harber, Robyn Cicarella, Gene Neytman, Jack Herman, Craig Herman, Mariam Aziz, Joan Swiatek, Divya Pathak, Madhu Choudhary, Jennifer Sullivano, Olayemi Osiyemi, Myriam Izquierdo, Odelsey Torna, Aleen Khodabakhshian, Samantha Fortier, Constance Benson, Steven Hendrickx, Rosemarie Ramirez, Anne Luetkemeyer, Suzanne Hendler, Dennis Dentoni-Lasofsky, Mario Castro, Leslie Spikes, Chase Hall, Jonathan Oakes, Amy James Loftis, Pablo Tebas, William Short, Sarah McGuffin, Chris Jonsson, Rachel Presti, and Alem Haile
- Subjects
Inhaled interferon ,SARS-CoV-2 ,COVID-19 ,ACTIV-2 ,Randomized clinical trial ,Medicine (General) ,R5-920 - Abstract
Summary: Background: With the emergence of SARS-CoV-2 variants resistant to monoclonal antibody therapies and limited global access to therapeutics, the evaluation of novel therapeutics to prevent progression to severe COVID-19 remains a critical need. Methods: Safety, clinical and antiviral efficacy of inhaled interferon-β1a (SNG001) were evaluated in a phase II randomized controlled trial on the ACTIV-2/A5401 platform (ClinicalTrials.gov NCT04518410). Adult outpatients with confirmed SARS-CoV-2 infection within 10 days of symptom onset were randomized and initiated either orally inhaled nebulized SNG001 given once daily for 14 days (n = 110) or blinded pooled placebo (n = 110) between February 10 and August 18, 2021. Findings: The proportion of participants reporting premature treatment discontinuation was 9% among SNG001 and 13% among placebo participants. There were no differences between participants who received SNG001 or placebo in the primary outcomes of treatment emergent Grade 3 or higher adverse events (3.6% and 8.2%, respectively), time to symptom improvement (median 13 and 9 days, respectively), or proportion with unquantifiable nasopharyngeal SARS-CoV-2 RNA at days 3 (28% [26/93] vs. 39% [37/94], respectively), 7 (65% [60/93] vs. 66% [62/94]) and 14 (91% [86/95] vs. 91% [83/81]). There were fewer hospitalizations with SNG001 (n = 1; 1%) compared with placebo (n = 7; 6%), representing an 86% relative risk reduction (p = 0.07). There were no deaths in either arm. Interpretation: In this trial, SNG001 was safe and associated with a non-statistically significant decrease in hospitalization for COVID-19 pneumonia. Funding: The ACTIV-2 platform study is funded by the NIH. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636 and UM1 AI106701. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
- Published
- 2023
- Full Text
- View/download PDF
48. Chemical characterization of milk oligosaccharides of the common wombat (Vombatus ursinus)
- Author
-
Megumi Kikuchi, Tadasu Urashima, Epi Taufik, Kenji Fukuda, Michael Messer, Keith Newgrain, Kentaro Hirayama, Brian Green, Tadashi Nakamura, and Tadao Saito
- Subjects
0301 basic medicine ,biology ,Chemistry ,Common wombat ,General Medicine ,Biological evolution ,Carbohydrate ,biology.organism_classification ,Molecular biology ,carbohydrates (lipids) ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,Sulfation ,Lactose ,General Agricultural and Biological Sciences - Abstract
Previous structural characterizations of marsupial milk oligosaccharides have been performed in the tammar wallaby, red kangaroo, koala, common brushtail possum and the eastern quoll. To clarify the homology and heterogeneity of milk oligosaccharides among marsupial species, which could provide information on their evolution, the oligosaccharides of wombat milk carbohydrate were characterized in this study. Neutral and acidic oligosaccharides were isolated from the carbohydrate fractions of two samples of milk of the common wombat and characterized by (1) H-nuclear magnetic resonance spectroscopy. The structures of six neutral saccharides were found to be Gal(β1-4)Glc (lactose), Gal(β1-3)Gal(β1-4)Glc (3'-galactosyllactose), Gal(β1-3)Gal(β1-3)Gal(β1-4)Glc (3',3"-digalactosyllactose), Gal(β1-3)Gal(β1-3)Gal(β1-3)Gal(β1-4)Glc, Gal(β1-3)Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)Glc (galactosyl lacto-N-novopentaose I) and Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)Glc (lacto-N-novooctaose), while those of six acidic saccharides were Neu5Ac(α2-3)Gal(β1-3)Gal(β1-4)Glc. (sialyl 3'-galactosyllactose), Neu5Ac(α2-3)Gal(β1-3)Gal(β1-3)Gal(β1-4)Glc (sialyl 3',3"-digalactosyllactose), Neu5Ac(α2-3)Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)Glc (sialyl lacto-N-novopentaose a), Gal(β1-3)[Neu5Ac(α2-3)Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)Glc (sialyl lacto-N-novopentaose c), Neu5Ac(α2-3)Gal(β1-3)Gal(β1-3)Gal(β1-3)Gal(β1-4)Glc,, Neu5Ac(α2-3)Gal(β1-3)Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)Glc and Gal(β1-3)Gal(β1-3)[Neu5Ac(α2-3)Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)Glc. In addition, small amounts of sulfated oligosaccharides but no oligosaccharides containing Neu5Gc or α(2-6) linked Neu5Ac were detected.
- Published
- 2015
49. The ‘sticky’ ITCZ: ocean-moderated ITCZ shifts
- Author
-
John Marshall, Brian Green, Jean-Michel Campin, and Massachusetts Institute of Technology. Department of Earth, Atmospheric, and Planetary Sciences
- Subjects
Atmospheric Science ,010504 meteorology & atmospheric sciences ,Intertropical Convergence Zone ,Ocean current ,Equator ,Energy balance ,Forcing (mathematics) ,010502 geochemistry & geophysics ,01 natural sciences ,Latitude ,Climatology ,Environmental science ,Climate model ,Hadley cell ,Physics::Atmospheric and Oceanic Physics ,0105 earth and related environmental sciences - Abstract
Across a range of simulations with a coupled atmosphere–ocean climate model, shifts in the intertropical convergence zone (ITCZ) are induced by an interhemispheric heating contrast. The response to heating anomalies which are polar amplified are contrasted with those which are largest in the tropics. First, we find that ITCZ shifts are always damped relative to simulations in which the ocean circulation is held fixed, irrespective of the heating distribution, keeping the ITCZ “stuck” to latitudes near the equator. The damping is primarily due to the ocean’s anomalous cross-equatorial energy transport associated with the coupling of the trade winds to an oceanic cross-equatorial cell (CEC). Second, we find that the damping effect is strongest when the forcing distribution is polar-amplified, which enhances the gross stability of the CEC and maximizes the efficiency of its cross-equatorial energy transport. Third, we argue that the ocean’s energy transport can have secondary impacts on ITCZ shifts through its interaction with climate feedbacks. Finally, we discuss the implications of our study for our understanding of the role of CECs in damping ITCZ shifts and the atmosphere’s energy balance.
- Published
- 2018
50. Comparative Pathogenesis of Asian and African-Lineage Zika Virus in Indian Rhesus Macaque’s and Development of a Non-Human Primate Model Suitable for the Evaluation of New Drugs and Vaccines
- Author
-
Jon O. Rayner, Brian Green, Raj Kalkeri, Shuling Lin, Scott Goebel, Kevin B. Walters, Zhaohui Cai, Kimberly Hagelin, Beth A. Snyder, and Fusataka Koide
- Subjects
0301 basic medicine ,Lineage (genetic) ,lcsh:QR1-502 ,Heterologous ,Viremia ,NHP ,Biology ,Article ,lcsh:Microbiology ,Zika virus ,03 medical and health sciences ,rhesus macaques ,Immune system ,ZIKV ,Non-human primates ,infection ,natural history ,Asian-lineage ,African-lineage ,Immunity ,Virology ,medicine ,Animals ,Humans ,Zika Virus Infection ,Viral Load ,biology.organism_classification ,medicine.disease ,Macaca mulatta ,Rhesus macaque ,Disease Models, Animal ,030104 developmental biology ,Infectious Diseases ,Viral load - Abstract
The establishment of a well characterized non-human primate model of Zika virus (ZIKV) infection is critical for the development of medical interventions. In this study, challenging Indian rhesus macaques (IRMs) with ZIKV strains of the Asian lineage resulted in dose-dependent peak viral loads between days 2 and 5 post infection and a robust immune response which protected the animals from homologous and heterologous re-challenge. In contrast, viremia in IRMs challenged with an African lineage strain was below the assay’s lower limit of quantitation, and the immune response was insufficient to protect from re-challenge. These results corroborate previous observations but are contrary to reports using other African strains, obviating the need for additional studies to elucidate the variables contributing to the disparities. Nonetheless, the utility of an Asian lineage ZIKV IRM model for countermeasure development was verified by vaccinating animals with a formalin inactivated reference vaccine and demonstrating sterilizing immunity against a subsequent subcutaneous challenge.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.